Arkolith/Insider Trading/ADIL

ADIL Insider Trading

Adial Pharmaceuticals, Inc. · full profile →Last filing Jul 16, 2026
Net Buying · 180d
Open-Market Buys (180d)
$106K
1 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$106K
open market, 180d
Reporting Insiders
1
5 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jul 16, 2026Coastlands Capital LP10% OwnerBuy(P)1K$2.75$3K
Jul 14, 2026Coastlands Capital LP10% OwnerBuy(P)2K$2.65$5K
Jul 10, 2026Coastlands Capital LP10% OwnerBuy(P)2K$2.70$5K
Jul 9, 2026Coastlands Capital LP10% OwnerBuy(P)10K$2.79$28K
Jun 29, 2026Coastlands Capital LP10% OwnerBuy(P)25K$2.60$65K
Jun 12, 2026Young Wendy B.DirectorBuy(P)36K$2.75$100K
Jun 12, 2026Davidson MattChief Development Officer, DirectorGrant(A)232K—$0
Jun 12, 2026Davidson MattChief Development Officer, DirectorGrant(A)232K—$0
Jun 11, 2026Davidson MattChief Development Officer, DirectorGrant(A)62K——
Jun 11, 2026Davidson MattChief Development Officer, DirectorGrant(A)3K——
Jun 11, 2026Davidson MattChief Development Officer, DirectorGrant(A)2K——
Jun 11, 2026Davidson MattChief Development Officer, DirectorGrant(A)101——
Apr 7, 2026Claiborne Cary JChief Executive Officer, DirectorGrant(A)38K—$0
Apr 7, 2026Gilliland Robertson H.DirectorGrant(A)9K—$0
Apr 7, 2026Schuyler KevinDirectorGrant(A)9K—$0
Apr 7, 2026Shah VinayChief Financial OfficerGrant(A)17K—$0
Apr 7, 2026Goodman TonyChief Operating Officer, DirectorGrant(A)27K—$0
Apr 7, 2026Anderson J. KermitDirectorGrant(A)9K—$0
May 29, 2025Anderson J. KermitDirectorGrant(A)28K—$0
May 29, 2025Goodman TonyChief Operating Officer, DirectorGrant(A)94K—$0
May 29, 2025Claiborne Cary JChief Executive Officer, DirectorGrant(A)138K—$0
May 29, 2025Schuyler KevinDirectorGrant(A)28K—$0
May 29, 2025Shah VinayChief Financial OfficerGrant(A)9K—$0
May 29, 2025Newman James W. Jr.DirectorGrant(A)28K—$0
May 29, 2025Gilliland Robertson H.DirectorGrant(A)28K—$0
Dec 5, 2024Claiborne Cary JChief Executive Officer, DirectorGrant(A)350K—$0
Nov 16, 2024Shah VinayChief Financial OfficerGrant(A)40K—$0
Mar 25, 2024Goodman TonyChief Operating Officer, DirectorGrant(A)42K—$0
Mar 25, 2024Schuyler KevinDirectorGrant(A)12K—$0
Mar 25, 2024Anderson J. KermitDirectorGrant(A)12K—$0
Mar 25, 2024Claiborne Cary JChief Executive Officer, DirectorGrant(A)60K—$0
Mar 25, 2024Truluck JosephChief Financial OfficerGrant(A)25K—$0
Mar 25, 2024Newman James W. Jr.DirectorGrant(A)12K—$0
Mar 25, 2024Gilliland Robertson H.DirectorGrant(A)12K—$0
Sep 29, 2023Schuyler KevinDirectorBuy(P)700$2.74$2K
May 23, 2023Anderson J. KermitDirectorGrant(A)50K—$0
May 23, 2023Claiborne Cary JChief Executive Officer, DirectorGrant(A)420K—$0
May 23, 2023Claiborne Cary JChief Executive Officer, DirectorGrant(A)300K—$0
May 23, 2023Gilliland Robertson H.DirectorGrant(A)50K—$0
May 23, 2023Goodman TonyDirectorGrant(A)50K—$0
May 23, 2023Newman James W. Jr.DirectorGrant(A)50K—$0
May 23, 2023Schuyler KevinDirectorGrant(A)50K—$0
May 23, 2023Stilley William B. IIIDirectorGrant(A)241K—$0
May 23, 2023Stilley William B. IIIDirectorGrant(A)50K—$0
May 23, 2023Truluck JosephChief Financial OfficerGrant(A)158K—$0
May 23, 2023Truluck JosephChief Financial OfficerGrant(A)125K—$0
May 23, 2023Johnson Bankole A.DirectorGrant(A)40K—$0
Dec 30, 2022Stilley William B. IIIDirectorDisposed to issuer(D)167K—$0
Sep 20, 2022Claiborne Cary JChief Executive Officer, DirectorGrant(A)75K$0.42$32K
Sep 19, 2022Claiborne Cary JChief Executive Officer, DirectorGrant(A)25K$0.43$11K
Aug 22, 2022Stilley William B. IIIDirectorGrant(A)100K—$0
Aug 18, 2022Claiborne Cary JChief Executive OfficerGrant(A)1.0M—$0
Jun 27, 2022Goodman TonyDirectorGrant(A)25K—$0
Feb 23, 2022Anderson J. KermitDirectorGrant(A)40K—$0
Feb 23, 2022Claiborne Cary JChief Operating OfficerGrant(A)7K—$0
Feb 23, 2022Gilliland Robertson H.DirectorGrant(A)40K—$0
Feb 23, 2022Newman James W. Jr.DirectorGrant(A)40K—$0
Feb 23, 2022Schuyler KevinDirectorGrant(A)40K—$0
Feb 23, 2022Stilley William B. IIIChief Executive Officer, DirectorGrant(A)250K—$0
Feb 23, 2022Truluck JosephChief Financial OfficerGrant(A)100K—$0
Feb 23, 2022Goodman TonyDirectorGrant(A)40K—$0
Feb 23, 2022Johnson Bankole A.Chief Medical OfficerGrant(A)35K—$0
Dec 30, 2021Newman James W. Jr.DirectorBuy(P)10K$2.66$27K
Dec 30, 2021Newman James W. Jr.DirectorBuy(P)5K$2.72$14K
Dec 30, 2021Newman James W. Jr.DirectorBuy(P)10K$2.71$27K
Dec 23, 2021Schuyler KevinDirector, 10% OwnerGift(G)313K—$0
Dec 23, 2021Schuyler KevinDirector, 10% OwnerGift(G)90K—$0
Dec 7, 2021Claiborne Cary JChief Operating Officer, DirectorGrant(A)130K—$0
Nov 30, 2021Stilley William B. IIIChief Executive Officer, Director, 10% OwnerBuy(P)11K$2.75$29K
Nov 29, 2021Stilley William B. IIIChief Executive Officer, Director, 10% OwnerBuy(P)10K$2.59$26K
Nov 26, 2021Newman James W. Jr.DirectorBuy(P)10K$2.85$29K
Nov 2, 2021Claiborne Cary JDirectorGrant(A)60K—$0
Oct 4, 2021Johnson Bankole A.Chief Medical OfficerSell(S)200K——
Oct 4, 2021Johnson Bankole A.Chief Medical OfficerOther(J)150K——
Apr 6, 2021Johnson Bankole A.Chief Medical OfficerSell(S)150K$2.50$375K
Feb 8, 2021Anderson J. KermitDirectorGrant(A)40K—$0
Feb 8, 2021Gilliland Robertson H.DirectorGrant(A)40K—$0
Feb 8, 2021Goodman TonyDirectorGrant(A)40K—$0
Feb 8, 2021Newman James W. Jr.DirectorGrant(A)40K—$0
Feb 8, 2021Schuyler KevinDirectorGrant(A)40K—$0
Feb 8, 2021Stilley William B. IIIChief Executive Officer, DirectorGrant(A)250K—$0
Feb 8, 2021Truluck JosephChief Financial OfficerGrant(A)125K—$0
Jan 26, 2021Newman James W. Jr.DirectorGrant(A)3K——
Jan 26, 2021Newman James W. Jr.DirectorGrant(A)1K——
Jan 26, 2021Stilley William B. IIIChief Executive Officer, Director, 10% OwnerGrant(A)201K——
Nov 23, 2020Schuyler KevinDirectorGift(G)1K——
Nov 23, 2020Schuyler KevinDirectorGift(G)9K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Nov 23, 2020Schuyler KevinDirectorGift(G)82K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Nov 23, 2020Schuyler KevinDirectorGift(G)1K——
Nov 23, 2020Schuyler KevinDirectorGift(G)9K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Nov 23, 2020Schuyler KevinDirectorGift(G)82K——
Nov 23, 2020Schuyler KevinDirectorGift(G)90K——
Aug 20, 2020Johnson Bankole A.Chief Medical OfficerSell(S)350K$1.21$424K
May 19, 2020Reich Jack WDirectorGrant(A)90K—$0
Mar 27, 2020Newman James W. Jr.DirectorBuy(P)10K$1.34$13K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Adial Pharmaceuticals, Inc., SEC CIK 0001513525. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ADIL and shows every filing by that issuer.

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-10. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for ADIL